Big Gain For ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. (THMO:NASDAQ) rocketted at $0.3, a gain of 30.8%. On Wed, Jul 06, 2022, THMO:NASDAQ touched a New 2-Week High of $0.3. From Wed, Jun 22, 2022, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Wed, Jul 06, 2022 at $0.51 with a volume of 60M+.

About ThermoGenesis Holdings, Inc. (THMO:NASDAQ)

ThermoGenesis Holdings, Inc. is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. ThermoGenesis Holdings, Inc.'s clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets.